meta_pixel
Tapesearch Logo
Log in
NutritionFacts.org Video Podcast

The Benefits of Turmeric Curcumin for Arthritis, Blood Sugar, Cholesterol, and Body Weight

NutritionFacts.org Video Podcast

Michael Greger, M.D. FACLM

Nutrition, Alternative Health, Health & Fitness

4.8951 Ratings

🗓️ 16 February 2026

⏱️ 5 minutes

🧾️ Download transcript

Summary

Dozens of human trials reveal where turmeric delivers—and where it doesn’t.

Transcript

Click on a timestamp to play from that location

0:00.0

The number of clinical trials on turmeric, not in rats or petri dishes, but with actual people,

0:12.0

continues to climb dozens a year, and most were randomized double-blind placebo-controlled,

0:18.0

the gold standard for clinical trials.

0:25.6

There have been so many trials published that there are now umbrella reviews on turmeric.

0:30.6

You've heard of systematic reviews and meta-analyses, pooling multiple studies together.

0:37.9

Well, an umbrella review can be like a systematic review and meta-analysis of systematic reviews and meta-analyses,

0:43.9

meaning pooling multiple meta-analyses together, placing them at the very top of the hierarchy of evidence pyramid. Dr. Greger has covered the benefits of the tumor pigment curcumin for knee

0:49.5

osteoarthritis. In some cases working as well as or even better than anti-inflammatory drugs and

0:55.4

painkillers without their side effects of injuring our gut. And in the 10 years since, a meta-analysis

1:02.0

of 11 meta-analyses on the efficacy of carcumin for relieving osteoarthritis strongly supports that it can

1:08.6

relieve pain as well as improve joint mobility and shorten medication

1:12.4

use. And more isn't necessarily better. Low-dose extracts appear to have similar pain relief

1:18.9

effects to high-dose extracts. What about other arthritic conditions? A pilot study in 2012 of

1:26.4

45 patients showed promise for rheumatoid arthritis, finding it is actually

1:30.5

more effective at alleviating pain compared to the leading drug.

1:34.4

And a recent meta-analysis, including more than 500 patients, found the same.

1:39.1

Kirkuman was beneficial, both for inflammation levels and clinical symptoms.

1:51.0

Kirkuman's ability to lower some inflammatory biomarkers, like C-reactive protein, a marker of systemic inflammation, extends more broadly to patients with auto-inflammatory conditions, and the stronger effects seem to appear at relatively smaller doses.

2:00.0

You may recall that Dr. Greger talked about a 2012 study

2:03.2

in pre-diabetic individuals, where 0% of those taking carcumin extract for nine months

2:08.4

progressed to type 2 diabetes, while 16% of those on placebo did. There have been a lot of

2:15.7

studies since. 14 systematic reviews and meta-analyses containing 61 individual randomized controlled trials were included in this umbrella review.

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from Michael Greger, M.D. FACLM, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Michael Greger, M.D. FACLM and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.